ZA952244B - Recombinant viruses their preparation and their use in gene therapy - Google Patents
Recombinant viruses their preparation and their use in gene therapyInfo
- Publication number
- ZA952244B ZA952244B ZA952244A ZA952244A ZA952244B ZA 952244 B ZA952244 B ZA 952244B ZA 952244 A ZA952244 A ZA 952244A ZA 952244 A ZA952244 A ZA 952244A ZA 952244 B ZA952244 B ZA 952244B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- gene therapy
- recombinant viruses
- viruses
- recombinant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Psychiatry (AREA)
- Plant Pathology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9403191A FR2717496B1 (fr) | 1994-03-18 | 1994-03-18 | Virus recombinants, préparation et utilisation en thérapie génique. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA952244B true ZA952244B (en) | 1996-01-16 |
Family
ID=9461190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA952244A ZA952244B (en) | 1994-03-18 | 1995-03-17 | Recombinant viruses their preparation and their use in gene therapy |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0750676A1 (fr) |
JP (1) | JPH09510358A (fr) |
KR (1) | KR970701784A (fr) |
AU (1) | AU703793B2 (fr) |
CA (1) | CA2184200A1 (fr) |
FI (1) | FI963674A0 (fr) |
FR (1) | FR2717496B1 (fr) |
IL (1) | IL112992A0 (fr) |
MX (1) | MX9603490A (fr) |
NO (1) | NO963559L (fr) |
WO (1) | WO1995025804A1 (fr) |
ZA (1) | ZA952244B (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830857A (en) * | 1995-07-14 | 1998-11-03 | Amgen Inc. | Method of treating epilepsy |
FR2753379B1 (fr) * | 1996-09-13 | 1998-10-30 | Rhone Poulenc Rorer Sa | Methode de traitement de la sclerose laterale amyotrophique |
ES2322332T3 (es) * | 2000-05-05 | 2009-06-19 | The Research Foundation Of The City University Of New York | Composiciones para estimular la regeneracion del sistema nervioso y reparacion mediante la regulacion de la sintesis de poliamidas y arginasa 1. |
EP3755380A4 (fr) * | 2018-02-20 | 2021-12-08 | Carmel-Haifa University Economic Corporation Ltd. | Compositions et procédés pour l'administration et l'expression de petits peptides inhibiteurs et leur utilisation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT70275A (en) * | 1991-07-10 | 1995-09-28 | Regeneron Pharma | Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
WO1993008828A1 (fr) * | 1991-11-08 | 1993-05-13 | Syntex-Synergen Neuroscience Joint Venture | Traitements de lesions neuronales liees a l'ischemie, a l'hypoxie ou a la degenerescence neuronale |
FR2688514A1 (fr) * | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant. |
WO1994003199A1 (fr) * | 1992-08-04 | 1994-02-17 | Regeneron Pharmaceuticals, Inc. | Procede ameliorant la differentiation et les chances de survie des cellules precurseurs neuronales |
WO1994008026A1 (fr) * | 1992-09-25 | 1994-04-14 | Rhone-Poulenc Rorer S.A. | Vecteurs d'adenovirus pour le transfert de genes etrangers dans des cellules du systeme nerveux central, en particulier du cerveau |
FR2704234B1 (fr) * | 1993-04-22 | 1995-07-21 | Centre Nat Rech Scient | Virus recombinants, preparation et utilisation en therapie genique. |
-
1994
- 1994-03-18 FR FR9403191A patent/FR2717496B1/fr not_active Expired - Fee Related
-
1995
- 1995-03-02 KR KR1019960705207A patent/KR970701784A/ko not_active Application Discontinuation
- 1995-03-02 JP JP7524417A patent/JPH09510358A/ja active Pending
- 1995-03-02 AU AU18962/95A patent/AU703793B2/en not_active Ceased
- 1995-03-02 CA CA002184200A patent/CA2184200A1/fr not_active Abandoned
- 1995-03-02 MX MX9603490A patent/MX9603490A/es not_active Application Discontinuation
- 1995-03-02 EP EP95911371A patent/EP0750676A1/fr not_active Ceased
- 1995-03-02 WO PCT/FR1995/000250 patent/WO1995025804A1/fr not_active Application Discontinuation
- 1995-03-14 IL IL11299295A patent/IL112992A0/xx unknown
- 1995-03-17 ZA ZA952244A patent/ZA952244B/xx unknown
-
1996
- 1996-08-26 NO NO963559A patent/NO963559L/no not_active Application Discontinuation
- 1996-09-17 FI FI963674A patent/FI963674A0/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL112992A0 (en) | 1995-06-29 |
CA2184200A1 (fr) | 1995-09-28 |
FR2717496B1 (fr) | 1996-04-12 |
KR970701784A (ko) | 1997-04-12 |
AU1896295A (en) | 1995-10-09 |
JPH09510358A (ja) | 1997-10-21 |
FI963674A (fi) | 1996-09-17 |
NO963559L (no) | 1996-08-26 |
WO1995025804A1 (fr) | 1995-09-28 |
FR2717496A1 (fr) | 1995-09-22 |
EP0750676A1 (fr) | 1997-01-02 |
AU703793B2 (en) | 1999-04-01 |
FI963674A0 (fi) | 1996-09-17 |
MX9603490A (es) | 1997-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA949104B (en) | Recombinant viruses and their use in gene therapy | |
ZA951803B (en) | Recombinant viruses their preparation and their therapeutic use | |
ZA952563B (en) | Recombinant viruses their preparation and their use in gene therapy | |
IL115584A0 (en) | Viral vectors and their use in gene therapy | |
AU4032893A (en) | Human papilloma virus genes and their use in gene therapy | |
ZA945012B (en) | Viral vectors and their use in gene therapy | |
IL113844A (en) | N-(alpha-ETHYLBENZYL)-3-HYDROXY-2-PHENYLQUINOLINE-4-CARBOXAMIDE AND ITS USE IN THE PREPARATION OF MEDICAMENTS | |
HUP9801216A3 (en) | Dna molecules, preparation thereof and use thereof in gene therapy | |
HU9503751D0 (en) | Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection | |
SG54275A1 (en) | Dna coding for decarbamylase improved in thermostability and use thereof | |
ZA949103B (en) | Recombinant viruses and their use in gene therapy | |
EP0752472A4 (fr) | Nouveau gene tire de corynebacterium et son utilisation | |
ZA956849B (en) | Use of a defective recombinant adenovirus in gene therapy | |
IL117466A0 (en) | Recombinant viruses expressing lecithin-cholesterol acryltransferase and their use in gene therapy | |
GB9419553D0 (en) | Polypeptides and their use in the treatment of auto-immune disease | |
IL112075A0 (en) | Recombinant human thymopoietin proteins, their preparation and their medicinal use | |
ZA952242B (en) | Recombinant viruses their preparation and their use in gene therapy | |
ZA964563B (en) | Isoindole derivatives their preparation and their application in therapy | |
ZA952244B (en) | Recombinant viruses their preparation and their use in gene therapy | |
IL128902A0 (en) | N-(2-benzothiazolyl)-1-piperidineethanamine derivatives their preparation and their use in therapy | |
ZA959904B (en) | Iminooxymethyleneanilides thei preparation and their use | |
IL113725A0 (en) | Preparing recombinant aprotini and its variants | |
ZA952286B (en) | Recombinant viruses their preparation and their use in gene therapy | |
ZA952243B (en) | Recombinant viruses their preparation and their use in gene therapy | |
ZA976547B (en) | Lipid-binding proteins and their therapeutic and diagnostic use |